Although inhibition of MLK1 by siRNA was shown to facilitate anti-proliferation effects in vitro using pancreatic cell lines [7], it is not clear whether using small molecules targeting MLK1 can suppress pancreatic cancers in an animal model. This evidence concerns the gene MAP3K9 and pancreatic neoplasm.